$1.07
▼ -7.8% Today
as of Oct 22, 16:50 ET
Last 30 days
Recent Press Releases & News
Marker Therapeutics Awarded $2.6 Million FDA Orphan Products Development Grant to Advance MT-601 in Pancreatic Cancer
All You Need to Know About MARKER THERAPEUTICS (MRKR) Rating Upgrade to Strong Buy
Marker Therapeutics Highlights Expanded Manufacturing Support of CDMO Partner Following Formation of Kincellis Advanced Therapies
MRKR earnings at a glance
Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±1.8% on average; after the most recent report on May 15, 2026 it moved -2.7%. MRKR beat the consensus EPS estimate in 4 of its last 4 reported quarters. The share price of $1.07 sits near its 52-week low.
Overview
52-week range
$0.84
$2.46
14% of range
Avg surprise (last 4)
+45.1%
Avg reaction (last 2)
-0.9%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.09 | — | — | — | — | financials |
| Fri May 15, 2026 | Mar/2026 | $-0.16 | $-0.18 | +11.1% | +60.0% | -2.7% | earnings |
| Thu Nov 13, 2025 | Sep/2025 | $-0.12 | $-0.69 | +82.6% | — | — | earnings |
| Thu Aug 14, 2025 | Jun/2025 | $-0.29 | $-0.55 | +47.3% | — | — | earnings |
| Thu May 15, 2025 | Mar/2025 | $-0.40 | $-0.66 | +39.4% | — | +0.9% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.26 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.25 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.27 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.34 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.29 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.57 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $751,691 | — | $1M | $861,184 | $349,104 | — | $2M |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-3M | $-4M | — | $-2M | $-5M | $-5M | — | $-2M |
| Net income | $-2M | $-3M | — | $-2M | $-4M | $-4M | — | $-2M |
| EPS (diluted) | $-0.09 | $-0.16 | — | $-0.12 | $-0.29 | $-0.40 | — | $-0.26 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $11M | $15M | $16M | $18M | $10M | $14M | $19M | $9M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $15M | $17M | $19M | $22M | $15M | $17M | $22M | $11M |
| Total assets | $15M | $17M | $19M | $22M | $15M | $17M | $22M | $11M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $2M | $4M | $2M | $3M | $4M | $3M | $3M | $3M |
| Total equity | $12M | $14M | $17M | $18M | $10M | $14M | $19M | $7M |
Implied volatility — last 90 days
No IV snapshots yet for MRKR.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
MRKR earnings FAQ
How does MRKR stock usually react to earnings?
Across the last 2 reports the average next-day move was ±1.8%, up 1 times and down 1 times.